fb
X
X
Tired?
Unfocused?
Off your game?
Read our free, updated as of Mar 3, 2022, Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
YES, SEND ME THE REPORT !
Meet Dr K !
Chris Kacher
  • Nuclear physicist
  • Stock & crypto market wizard
  • Blockchain builder
  • Bestselling author
  • Top 40 charted musician
  • Biohacker
  • Former computer hacker
YES, SEND ME THE FILE !
YES, SEND ME BOTH !
Your email will always remain private.

SSS - Follow-Up on Apple (AAPL) and Alexion Pharmaceuticals (ALXN)

In our Pre-Market Pulse of this morning we discussed Alexion Pharmaceuticals (ALXN) as prime short-sale target based on its "classic" head and shoulders short-sale set-up. This morning the stock rallied into an optimal shorting area within 2% of its 50-day moving average. As of this writing the stock is trading down 1.53% as the 90.08 low of December 7th and the 86.20 low of November 8th come into play as downside targets. As we figure it, the neckline on ALXN's H&S formation is down around the 82 price level, so an undercut of the 86.20 low could coincide with a bounce off the 82-83 level, roughly around the neckline. The situation remains fluid, and there is always the possibility of being stopped out if the stock rallies beyond the 50-day moving average, but so far it has followed the 50-day line downward.

Apple (AAPL) appears more willing to test its own neckline under the 500 price level than stage any kind of rally that would form more right shoulders in its formation. If our thesis that AAPL will push towards the 500 price level is correct, then the stock should not get back above today's high at 513.97, and we would recommend using that as a near stop for those running a big, concentrated short position in AAPL, with the 10-day line at 520.13 as a maximum trailing stop.

This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
FOR OUR FREE MARKET LAB REPORT :
Copyright ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy